(Q48035625)

English

Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis

scientific article published on 15 September 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

0 references

Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

0 references

0 references

0 references

0 references

Plasmodium falciparum

0 references

sulfadoxine/pyrimethamine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Charles O Obonyo

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

Elizabeth A Juma

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

Bernhards R Ogutu

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

John M Vulule

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

Joseph Lau

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

publication date

15 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

101

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

117-126

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

A contrarian view of malaria therapy policy in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Intensity of malaria transmission and the evolution of drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

The evolution of drug-resistant malaria: the role of drug elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Antimalarial combinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Clindamycin as an antimalarial drug: review of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Effects of artemisinin derivatives on malaria transmissibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Using evidence to change antimalarial drug policy in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Preventing antimalarial drug resistance through combinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

The process of changing national malaria treatment policy: lessons from country-level studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.07.001

7 January 2021

Identifiers

10.1016/J.TRSTMH.2006.07.001

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16978673

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48035625&oldid=2182470658"